Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.

1 Jan 1997

Abstract excerpt

PURPOSE: To evaluate the prognostic role of MYCN oncogene amplification in children with neuroblastoma. PATIENTS AND METHODS: Of 694 children (age, 0 to 15 years) with previously untreated neuroblastoma, 295 (42%) were evaluated at diagnosis for MYCN gene amplification. RESULTS: Clinical characteristics and survival results of 295 patients studied and 399 not studied for MYCN were comparable. In 48 of 295...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Cancer, Hypoxia, and Metabolism
Share to Neuroblastoma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8996128
DOI: 10.1200/jco.1997.15.1.85

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.PMID 8996128Read ↗

Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.Semantic proximity Read ↗

Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology GroupSemantic proximity Read ↗

Association of heterogeneous MYCN amplification with clinical features, biological characteristics and outcomes in neuroblastoma: A report from the Children's Oncology GroupSemantic proximity Read ↗

Neuroblastoma in Infants: Long Term Survival from INES Protocols - A SIOPEN StudySemantic proximity Read ↗

Neuroblastoma: the impact of biology and cooperation leading to personalized treatments.Semantic proximity Read ↗

MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screeningSemantic proximity Read ↗

Neuroblastoma.Semantic proximity Read ↗

Neuroblastoma in Infants: Long‐Term Survival From INES Protocols A SIOPEN StudySemantic proximity Read ↗

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children’s Oncology Group studySemantic proximity Read ↗

Neuroblastoma and MYCN.Semantic proximity Read ↗

Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma.Semantic proximity Read ↗

Influence of neuroblastoma stage on serum‐based detection of <i>MYCN</i> amplificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.